AU5090899A - Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors - Google Patents

Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors

Info

Publication number
AU5090899A
AU5090899A AU50908/99A AU5090899A AU5090899A AU 5090899 A AU5090899 A AU 5090899A AU 50908/99 A AU50908/99 A AU 50908/99A AU 5090899 A AU5090899 A AU 5090899A AU 5090899 A AU5090899 A AU 5090899A
Authority
AU
Australia
Prior art keywords
compositions
compounds
methods
immunosuppressive factors
endocytic presentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50908/99A
Inventor
Habib Zaghouani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tennessee Research Foundation
Original Assignee
University of Tennessee Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Tennessee Research Foundation filed Critical University of Tennessee Research Foundation
Publication of AU5090899A publication Critical patent/AU5090899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU50908/99A 1998-07-06 1999-07-06 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors Abandoned AU5090899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11112398A 1998-07-06 1998-07-06
US09111123 1998-07-06
PCT/US1999/015225 WO2000001732A2 (en) 1998-07-06 1999-07-06 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors

Publications (1)

Publication Number Publication Date
AU5090899A true AU5090899A (en) 2000-01-24

Family

ID=22336745

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50908/99A Abandoned AU5090899A (en) 1998-07-06 1999-07-06 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors

Country Status (4)

Country Link
EP (1) EP1093464A2 (en)
AU (1) AU5090899A (en)
CA (1) CA2331771A1 (en)
WO (1) WO2000001732A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10109618A1 (en) * 2001-02-28 2002-09-12 Eppendorf Ag Modifying antigen-presenting cells, useful e.g. in antitumor vaccines, by transfer to them of antigen-containing membrane fragments from diseased cells
US7332168B2 (en) 2000-08-22 2008-02-19 Micromet Ag Composition for the elimination of autoreactive B-cells
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
EP1474451A2 (en) * 2002-02-13 2004-11-10 Micromet AG De-immunized (poly)peptide constructs
GB0605735D0 (en) * 2006-03-22 2006-05-03 Immunobiology Ltd Composition and method for mediating an immune response
GB0615266D0 (en) * 2006-08-01 2006-09-06 Immunobiology Ltd Composition and method for mediating an immune response
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
CN108129554A (en) 2010-08-10 2018-06-08 洛桑聚合联合学院 Erythrocyte binding therapeutic agent
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
WO2015140648A2 (en) 2014-02-21 2015-09-24 Ecole Polytecnique Federale De Lausanne (Epfl) Epfl-Tto Glycotargeting therapeutics
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US11253579B2 (en) 2017-06-16 2022-02-22 The University Of Chicago Compositions and methods for inducing immune tolerance

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737057B1 (en) * 1997-01-07 2004-05-18 The University Of Tennessee Research Corporation Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors

Also Published As

Publication number Publication date
CA2331771A1 (en) 2000-01-13
WO2000001732A2 (en) 2000-01-13
EP1093464A2 (en) 2001-04-25
WO2000001732A3 (en) 2000-04-27

Similar Documents

Publication Publication Date Title
AU1621799A (en) Fungicidal compositions and methods, and compounds and methods for the preparation thereof
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
AU4048299A (en) Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same
AU1818100A (en) Desktop projection monitor
AU5194999A (en) Benzothiepin derivatives, process for the preparation of the same and uses thereof
AU6497600A (en) Peracid forming system, peracid forming composition, and methods for making and using
AU1935600A (en) Free form furniture
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU1595900A (en) Anti-cancer compounds and methods related thereto
AU4413299A (en) Stabilized pharmaceutical compositions
AU4851397A (en) Compositions for the preparation of leather
AU2349399A (en) R-lansoprazole compositions and methods
AU5090899A (en) Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
AU5565099A (en) Pharmaceutical compositions and methods for use
AU2035401A (en) Lubricant combination and process for the preparation thereof
AU2002231295A1 (en) Developed seed and methods for making the same
AU2108099A (en) Immunosuppressive agents
AU4996100A (en) (s,r) formoterol methods and compositions
AU2001292331A2 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU2001292331A1 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU7789800A (en) Stable multiple emulsion composition
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU1573600A (en) Microemulsion compositions
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AUPP332898A0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase